Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NOFTSE:4403 +1.14%89 EBITDA Margin % is 51.22% as of Mar. 2026, which is 124% above its 10-year median of 22.91. GuruFocus rates TSE:4403 with a GF Score™ of 89/100 and a GF Value™ of 円2,978.48 (Fairly Valued). Among 1,578 Chemicals companies, NOF ranks better than 94.3% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. NOF's EBITDA for the
three
months ended in Mar. 2026 was 円43,280 Mil. NOF's Revenue for the
three
months ended in Mar. 2026 was 円84,495 Mil. Therefore, NOF's EBITDA margin for the quarter that ended in Mar. 2026 was 51.22%.
NOF (TSE:4403) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
NOF EBITDA Margin % Related Terms
NOF EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for NOF's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4403 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, NOF's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NOF EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, NOF's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where NOF's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NOF (TSE:4403) has a EBITDA Margin % of 51.22% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NOF and its competitors. This is 124% above median its historical median of 22.91. Over the past decade, NOF's EBITDA Margin % has ranged from 16.98 to 30.85. According to the industry distribution chart, NOF ranks #90 out of 1578 companies in the Chemicals industry, placing it in the top 5.7%.
Is NOF's EBITDA Margin % too high?
NOF's current EBITDA Margin % of 51.22% is 124% above median its 10-year median of 22.91. Over the past 10 years, this metric has ranged from a low of 16.98 to a high of 30.85. The Chemicals industry median EBITDA Margin % is 9.64. NOF's value of 51.22% is 431.6% above this industry median. Based on the distribution chart, NOF ranks #90 out of 1578 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, NOF has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NOF's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, NOF ranks #90 out of 1578 companies for EBITDA Margin %. This places NOF in the top 6% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. NOF's value of 51.22% is 431.6% above this benchmark. Historically, NOF's own EBITDA Margin % has ranged from 16.98 to 30.85 over the past decade. While the company's 10-year median is 22.91 vs. the industry median of 9.64, NOF has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NOF's current EBITDA Margin % of 51.22% is 431.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NOF and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NOF's current EBITDA Margin % is 51.22%, which is 124% above median its own 10-year median of 22.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NOF stock overvalued right now?
Based on GuruFocus' analysis, NOF (TSE:4403) is currently considered Fairly Valued. The stock's GF Value™ is 円2,978.48, compared to a current price of 円2,751.00 — trading 7.6% below its estimated fair value. The current EBITDA Margin % is 51.22%, which is 124% above median its 10-year median of 22.91 and 431.6% above the Chemicals industry median of 9.64. NOF's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For NOF (TSE:4403), the current EBITDA Margin % is 51.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NOF (TSE:4403) Overvalued in 2026?
Based on GuruFocus' analysis, NOF stock appears to be undervalued.
The current stock price of 円2,751.00 is trading 7.6% below its estimated GF Value™ of 円2,978.48.
GuruFocus considers NOF to be Fairly Valued.
Key valuation signals for TSE:4403:
EBITDA Margin %: 51.22% (124% above median its 10-year median of 22.91)
GF Value™: 円2,978.48 vs. price of 円2,751.00 (7.6% below fair value)
Industry Position: 431.6% above the Chemicals median (#90 of 1578)
No single metric tells the full story. See the TSE:4403 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NOF Corp is engaged in the chemical manufacturing business. The Group has three reportable segments: Functional Chemicals Business, Pharmaceuticals, Medical and Healthcare Business, & Chemicals Business. The Functional Chemicals segment manufactures and sells fatty acids, surfactants, ethylene oxide/propylene oxide derivatives, organic peroxides, petrochemicals, functional polymers, electronic materials, and special rust prevention agents. The Pharmaceuticals, Medical and Healthcare segment produces pharmaceutical and functional food ingredients, health-related products, biocompatible materials, and raw materials for DDS pharmaceutical formulations. The Chemicals segment manufactures and sells industrial explosives, space-related products, defense-related products, and functional products.
89GF Score
Get the complete analysis for TSE:4403
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4403 has been successfully added to your 
